Search results

  1. InitialConditions

    Trial Report REGAIN: A Randomized Controlled Clinical Trial of Oxaloacetate for Improving the Symptoms of Long COVID, 2025, Vernon et al

    Are these tests actually legit? I never know whether they're just pure pseudoscience or not.
  2. InitialConditions

    Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome, 2025, Kouyoumdjian et al

    Yes, they've taken the ICC PENE critera (5 items) and just completely butchered them so that they become about 'tiredness'. Just bizzare. Why take the most strict/restrictive diagnostic criteria and then water them down? :confused:
  3. InitialConditions

    Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome, 2025, Kouyoumdjian et al

    Yes, I suppose you could look at it that way. I could have just written the first paragraph about the anomalously high prevalence rate in controls and then stopped! That probably would have been better!
  4. InitialConditions

    Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome, 2025, Kouyoumdjian et al

    I think this is clickbait. It's a grandiose statement going against conventional wisdom (that long covid is associated with ME/CFS) despite being based on an extremely low powered observational study.
  5. InitialConditions

    Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome, 2025, Kouyoumdjian et al

    I assumed the scoring system was their own invention. It's certainly nothing to do with the ICC. Now wondering if it's based on De Paul. If it is, they've not mentioned or even referened it at all.
  6. InitialConditions

    Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome, 2025, Kouyoumdjian et al

    I have left a comment. I don't have the energy to spend a long time on this, but I think I covered some of the main criticisms here. -- The authors report an ME/CFS prevalence rate of 10.8% in their control group. This is 10–20 times larger than the best estimates of the prevalence rate from...
  7. InitialConditions

    Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome, 2025, Kouyoumdjian et al

    It really seems to be a big problem now, made much worse by poor long covid research.
  8. InitialConditions

    Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome, 2025, Kouyoumdjian et al

    Will be interesting to see if this gets published. I have no doubt given scientific publishing and peer review standards that they'll find a home for it.
  9. InitialConditions

    Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome, 2025, Kouyoumdjian et al

    I don't even know where you'd start with this crap. Probably a lost cause.
  10. InitialConditions

    Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome, 2025, Kouyoumdjian et al

    It's not significant if your error bars are longer than a giraffe's neck.
  11. InitialConditions

    Exploration of Intersections and Divergences of Long COVID and Chronic Fatigue Syndrome, 2025, Kouyoumdjian et al

    This must be the most bizzare abstract I've read for many, many years.
  12. InitialConditions

    Stress dynamically modulates neuronal autophagy to gate depression onset - Yang et al., 2025

    Interesting links between chronic stress, depression, and autophagy, bringing in mOTR and the anti-depressive effects of rapamycin.
  13. InitialConditions

    Stress dynamically modulates neuronal autophagy to gate depression onset - Yang et al., 2025

    Chronic stress remodels brain homeostasis, in which persistent change leads to depressive disorders. As a key modulator of brain homeostasis, it remains elusive whether and how brain autophagy is engaged in stress dynamics. Here we discover that acute stress activates, whereas chronic stress...
  14. InitialConditions

    Myalgic Encephalomyelitis., M.E. a cure ?. Joy Anthony

    I'm afraid I'm skeptical of this story. Urine thyroid tests don't seem to be used at all, and are in fact recommended against, whereas blood thyroid tests are and have been for decades. Here's a paper in Dutch that concludes that 24-h urine tests for T3 and T4 are not accurate and cannot be used...
  15. InitialConditions

    Bisoprolol

    This paper suggests that bisoprolol has similar efficacy as propranolol for PoTS: https://www.neurotherapeuticsjournal.org/article/S1878-7479(23)01061-9/fulltext (I realise not all OI is PoTS.)
  16. InitialConditions

    Bisoprolol

    There's reasonably good evidence that propranolol improves symptoms of POTS, e.g., https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.108.846501, but I'm not sure its fully understood why. One theory is that excessive heart rates don't allow the heart to fill properly and so cardiac output...
  17. InitialConditions

    Replicated blood-based biomarkers for Myalgic Encephalomyelitis not explicable by inactivity, 2024, Beentjes, Ponting et al

    What is the stats/maths behind this statement, please, i.e., where does the 150 come from?
  18. InitialConditions

    Replicated blood-based biomarkers for Myalgic Encephalomyelitis not explicable by inactivity, 2024, Beentjes, Ponting et al

    Alan seems a touch angry, but I have to say, unless I am missing something, I am not really seeing the significance of this particular paper and its results, except for the fact some results have been replicated.
  19. InitialConditions

    Replicated blood-based biomarkers for Myalgic Encephalomyelitis not explicable by inactivity, 2024, Beentjes, Ponting et al

    I have one reading, from a medical I had at the University of Leeds in 2014, before extended fieldwork. The value was 214 iu/L, which wasn't flagged because the stated normal range was given as 70–300 iu/L, but looking now this range seems wrong for an adult and my result is actually high.
Back
Top Bottom